Cited by 211Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesPain Management and Opioid Use

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review

Open access

Carroll, Kathleen M., Weiss, Roger D.·2017·American Journal of Psychiatry

DOI 10.1176/appi.ajp.2016.16070792PMC PMC5474206

Open this paper in CoChat — free account

Abstract

OBJECTIVE: Although counseling is a required part of office-based buprenorphine treatment of opioid use disorders, the nature of what constitutes appropriate counseling is unclear and controversial. The authors review the literature on the role, nature, and intensity of behavioral interventions in office-based buprenorphine treatment. METHOD: The authors conducted a review of randomized controlled studies testing the efficacy of adding a behavioral intervention to buprenorphine maintenance treatment. RESULTS: Four key studies showed no benefit from adding a behavioral intervention to buprenorphine plus medical management, and four studies indicated some benefit for specific behavioral interventions, primarily contingency management. The authors examined the findings from the negative trials in the context of six questions: 1) Is buprenorphine that effective? 2) Is medical management that effective? 3) Are behavioral interventions that ineffective in this population? 4) How has research design affected the results of studies of buprenorphine plus behavioral treatment? 5) What do we know about subgroups of patients who do and those who do not seem to benefit from behavioral interventions? 6) What should clinicians aim for in terms of treatment outcome in buprenorphine maintenance? CONCLUSIONS: High-quality medical management may suffice for some patients, but there are few data regarding the types of individuals for whom medical management is sufficient. Physicians should consider a stepped-care model in which patients may begin with relatively nonintensive treatment, with increased intensity for patients who struggle early in treatment. Finally, with 6-month retention rates seldom exceeding 50% and poor outcomes following dropout, we must explore innovative strategies for enhancing retention in buprenorphine treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2016.16070792

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C. L., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,312
Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies: Mortality among opioid users
Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M., & McLaren, J. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03140.x · Cited by 856
A 33-Year Follow-up of Narcotics Addicts
Hser, Y., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.503 · Cited by 849
The Effects of Psychosocial Services in Substance Abuse Treatment
McLellan, A. T. (1993) · JAMA · doi:10.1001/jama.1993.03500150065028 · Cited by 827
National and state treatment need and capacity for opioid agonist medication-assisted treatment
Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302664 · Cited by 668
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R., Fry-Smith, A., Day, E., Lintzeris, N., Roberts, T. E., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11090 · Cited by 610
Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial
Weiss, R. D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.121 · Cited by 540
Self-citation
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
Hser, Y., Saxon, A. J., Huang, D., Hasson, A., Thomas, C., Hillhouse, M., Jacobs, P., Teruya, C., McLaughlin, P., Wiest, K., et al. (2014) · Addiction · doi:10.1111/add.12333 · Cited by 455
Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up.
Higgins, S. T., Wong, C. J., Badger, G. J., Ogden, D., & Dantona, R. L. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.1.64 · Cited by 352
Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence
Fiellin, D. A., Pantalon, M. V., Chawarski, M. C., Moore, B. A., Sullivan, L. E., O'Connor, P. G., & Schottenfeld, R. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055255 · Cited by 351

Show all 67 references

Research works printed but not linked: 3

[23]Ball JC Ross A The Effectiveness of Methadone Maintenance Treatment 1991 New York Springer-Verlag
[44]Institute of Medicine Panel on Handling Data in Clinical Trials. The Prevention and Treatment of Missing Data in Clinical Trials 2010 Washington, DC The National Academies Press 24983040
[64]Hoffman KA McCarty D Miller PM Improving the quality of addiction treatment Interventions for Addiction: Comprehensive Addictive Behaviors and Disorders 2013 San Diego, CA Academic Press 579 588

Sorted by citations

Items 101–200 of 210

Laboratory-induced stress and craving predict opioid use during follow-up among individuals with prescription opioid use disorder
Saraiya, T. C., Jarnecke, A. M., Jones, J. L., Brown, D. G., Brady, K. T., & Back, S. E. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108755 · Cited by 14
Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: a population-based observational study protocol
Guerra‐Alejos, B. C., Kurz, M., Min, J. E., Dale, L. M., Piske, M., Bach, P., Bruneau, J., Gustafson, P., Hu, X. J., Kampman, K. M., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068729 · Cited by 13
Anxiety and Opioid Use Disorder: Potential Targets for Treatment and Prevention
McHugh, R. K., Taghian, N. R., & Nguyen, M. D. (2021) · Current Addiction Reports · doi:10.1007/s40429-020-00350-8 · Cited by 16
Treating Opioid Use Disorder in General Medical Settings
(2021) · Springer eBooks · doi:10.1007/978-3-030-80818-1 · Cited by 14
“Today I can look in the mirror and like myself”: effects of a Trauma‐Informed mindful recovery program on self‐compassion
Moore, S. K., Okst, K., Smith, L., Fatkin, T., Creedon, T., Fredericksen, A. K., Gawande, R., & Schuman-Olivier, Z. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.780383 · Cited by 12
Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: a Narrative Review
Kimmel, S. D., Bach, P., & Walley, A. Y. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-05920-0 · Cited by 12
Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care
Cruz, A. M. D., Walker, R., Pipes, R., Wakhlu, S., & Trivedi, M. H. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-021-00222-0 · Cited by 11
A Harm Reduction Framework for Integrated Treatment of Co-Occurring Opioid Use Disorder and Trauma-Related Disorders
Israel, B. S., Belcher, A. M., & Ford, J. D. (2024) · Journal of Dual Diagnosis · doi:10.1080/15504263.2023.2295416 · Cited by 11
Supportive alternate site provision of buprenorphine: Overcoming barriers and improving patient outcomes
Khan, A. H., Khan, Q., & Kolb, E. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108256 · Cited by 10
Community-Based Yoga for Women Undergoing Substance Use Disorder Treatment
Galantino, M. L., Turetzkin, S., Lawlor, S., Jones, L., & Brooks, J. C. (2021) · International Journal of Yoga · doi:10.4103/ijoy.ijoy_103_20 · Cited by 10
Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use Disorder
Kennedy‐Hendricks, A., Schilling, C. J., Busch, A. B., Stuart, E. A., Huskamp, H. A., Meiselbach, M. K., Barry, C. L., & Eisenberg, M. D. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07094-9 · Cited by 10
Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study
Zullig, K. J., Lander, L. R., Tuscano, M., Garland, M., Hobbs, G. R., & Faulkenberry, L. (2021) · Mindfulness · doi:10.1007/s12671-021-01763-w · Cited by 10
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants
Andraka‐Christou, B., Page, C., Schoebel, V., Buche, J., & Haffajee, R. L. (2022) · Addiction Science & Clinical Practice · doi:10.1186/s13722-022-00321-6 · Cited by 10
Associations between Medication Assisted Therapy Services Delivery and Mortality in a National Cohort of Veterans with Posttraumatic Stress Disorder and Opioid Use Disorder
Riblet, N. B. V., Gottlieb, D. J., Shiner, B. R., Cornelius, S. L., & Watts, B. V. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1701218 · Cited by 10
Enhancing Addictions Education in Patient Care and Medical Knowledge Competencies for General Psychiatry Residents
Frank, A. A., Schwartz, A. C., Welsh, J. W., Ruble, A. E., Branch, R., DeMoss, D. S., & DeJong, S. M. (2022) · Academic Psychiatry · doi:10.1007/s40596-022-01634-z · Cited by 10
Community-Based Medications First for Opioid Use Disorder - Care Utilization and Mortality Outcomes
Banta‐Green, C. J., Owens, M. D., Williams, J. R., Floyd, A. S., Williams‐Gilbert, W., & Kingston, S. (2024) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s475807 · Cited by 9
Opioid Addiction/Pregnancy and Neonatal Abstinence Syndrome (NAS): A Preliminary Open-Label Study of Buprenorphine Maintenance and Drug Use Targeted Psychotherapy (DUST) on Cessation of Addictive Drug Use
Tabi, S., Heitner, S. A., Shivale, S., Minchenberg, S. B., Faraone, S. V., & Johnson, B. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.563409 · Cited by 9
Do people with opioid use disorder and posttraumatic stress disorder benefit from dding Individual opioid Drug Counseling to buprenorphine?
McHugh, R. K., Hilton, B. T., Chase, A. R., Griffin, M. L., & Weiss, R. D. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109084 · Cited by 9
Self-citation
A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial
Suzuki, J., Martin, B., Loguidice, F., Smelson, D. A., Liebschutz, J. M., Schnipper, J. L., & Weiss, R. D. (2023) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001162 · Cited by 9
Self-citation
Psychosocial Approaches in the Treatment of Opioid Use Disorders
Bergman, B. G., Fallah‐Sohy, N., Hoffman, L. A., & Kelly, J. F. (2019) · Current clinical psychiatry · doi:10.1007/978-3-030-16257-3_6 · Cited by 14
Assessing Motivations for Nonprescribed Buprenorphine Use Among Rural Appalachian Substance Users
McDonald, M. J., DeVeaugh‐Geiss, A., Chilcoat, H. D., & Havens, J. R. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001050 · Cited by 8
Learning Theory Principles for Psychotherapy
Rossiter, J. R. (2022) · Psychology · doi:10.4236/psych.2022.135049 · Cited by 8
Therapy Dose Mediates the Relationship Between Buprenorphine/Naloxone and Opioid Treatment Outcomes in Youth Receiving Medication for Opioid Use Disorder Treatment
Hammond, C. J., Kady, A., Park, G. S. H., Vidal, C., Wenzel, K. R., & Fishman, M. J. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000861 · Cited by 8
Buprenorphine Treatment for Opioid Use Disorder in Community‐Based Settings: Outcome Related to Intensity of Services and Urine Drug Test Results
Galanter, M. S., Femino, J., Hunter, B. D., & Hauser, M. (2020) · American Journal on Addictions · doi:10.1111/ajad.13001 · Cited by 7
Caring for Pregnant and Parenting Women with Opioid Use Disorder
Terplan, M., Martin, C. E., Premkumar, A., & Krans, E. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-80818-1_14 · Cited by 7
Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice
Cope, K., DeMicco, J., Salib, J., Michael, M., Yakoub, P., Daoud, K., & Cope, R. J. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001009 · Cited by 7
Epidemiology of Opioid Use, Misuse, and Overdoses
Draghmeh, K., Gold, M. S., & Fuehrlein, B. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00649-4 · Cited by 6
The Mobile Overdose Response Program: A mobile, low-threshold opioid use disorder treatment model in Philadelphia
Lowenstein, M., Popova, E., Jalloh, A., Mazzella, S., Botcheos, D., Bertocchi, J., Westfahl, S., Garcia, K. P., Truchil, R., & Chertok, J. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209429 · Cited by 6
Association between opioid analgesic therapy and initiation of buprenorphine management: An analysis of prescription drug monitoring program data
Alexandridis, A. A., Dasgupta, N., Ringwalt, C. L., Rosamond, W. D., Chelminski, P. R., & Marshall, S. W. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227350 · Cited by 6
Buprenorphine treatment receipt characteristics and retention among people who inject drugs at Integrated Care Centers in India
Ganapathi, L., McFall, A. M., Greco, K. F., Srikrishnan, A. K., Kumar, M. S., Mayer, K. H., O’Cleirigh, C. M., Mehta, S. H., Lucas, G. M., & Solomon, S. S. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109839 · Cited by 6
US physicians’ decision-making during buprenorphine-naloxone treatment: Conjoint analyses of dose and office visit adjustments based on patient progress
Knudsen, H. K., Lofwall, M. R., Lin, L. A., WALSH, S. L., & Studts, J. L. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.05.022 · Cited by 6
A Review of Relapse in Opioid Use Disorder
Draghmeh, K., Gold, M. S., & Fuehrlein, B. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00672-5 · Cited by 5
Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine
Petrakis, I. L., Meshberg‐Cohen, S., Nich, C., Kelly, M. M., Claudio, T., Jane, J. S., Pisani, E., & Ralevski, E. (2024) · American Journal on Addictions · doi:10.1111/ajad.13557 · Cited by 5
Buvidal/Brixadi – a long-acting injectable buprenorphine formulation for the treatment of opioid dependence
Lintzeris, N., & Dunlop, A. J. (2025) · Pain Management · doi:10.1080/17581869.2025.2555164 · Cited by 5
“I want to stay here”: Patient and staff perspectives on transitioning from a low-threshold buprenorphine program to clinic-based care
Martinez, N. G., Truong, A. Q., Nordeck, C. D., Agus, D., Genberg, B. L., & Buresh, M. E. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.111130 · Cited by 5
Treatment of insomnia associated with alcohol and opioid use: a narrative review
Akinnusi, M. E., Martinson, A. A., & El-Solh, A. (2024) · Sleep and Biological Rhythms · doi:10.1007/s41105-024-00544-x · Cited by 5
Treatment Retention in Opioid Dependent Clients Receiving Medication-Assisted Treatment: Six-Month Rate and Baseline Correlates
Fendrich, M., Becker, J., Ives, M. L., Rodis, E., & Marin, M. C. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1906276 · Cited by 5
Association of Counseling and Psychotherapy on Retention in Medication for Addiction Treatment Within a Large Medicaid Population
Eren, K., Schuster, J., Herschell, A. D., Loveland, D., Neimark, G. B., Mihalyo, M. J., Hurford, M. O., Houck, P. R., & Ryan, N. D. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000914 · Cited by 5
Urine drug testing among Medicaid enrollees initiating buprenorphine treatment for opioid use disorder within 9 MODRN states
Hammerslag, L. R., Talbert, J., Donohue, J. M., Sharbaugh, M. S., Ahrens, K. A., Allen, L., Austin, A. E., Gordon, A. J., Jarlenski, M., Kim, J. Y., et al. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110875 · Cited by 5
Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment
MacLean, R. R., Ankawi, B., Driscoll, M., Gordon, M. A., Frankforter, T. L., Nich, C., Szollosy, S. K., Loya, J. M., Brito, L., Ribeiro, M. I. P., et al. (2024) · JMIR Research Protocols · doi:10.2196/54342 · Cited by 6
“You Do More Difficult Things Than This”: A National Study of Nurse Practitioner Buprenorphine Prescribing
Speight, C., Perry, J., & Smirnova, O. (2024) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2023.104917 · Cited by 5
Drive and Instinct—How They Produce Relatedness and Addiction
Ringwood, T., Cox, L., Felldin, B., Kirsch, M., & Johnson, B. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.657944 · Cited by 5
Genesis of the Heroin-Induced Addictive Process: Articulation Between Psychodynamic and Neurobiological Theories
Scarna, H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.524764 · Cited by 5
Cognitive behavioral therapy for anxiety and opioid use disorder: Development and pilot testing
McHugh, R. K., Fitzmaurice, G. M., Votaw, V. R., Geyer, R. B., Ragnini, K., Greenfield, S. F., & Weiss, R. D. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209296 · Cited by 4
Self-citation
Behavioral Therapy as an Adjunct to Buprenorphine Treatment for Opioid Use Disorder
McHugh, R. K., Bailey, A. J., McConaghy, B. A., Weiss, R. D., Fiellin, D. A., Hillhouse, M. P., Moore, B. A., & Fitzmaurice, G. M. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.28529 · Cited by 4
Self-citation
Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder
Hefner, K. R., Choo, T.-H. J., Shmueli‐Blumberg, D., Pavlicová, M., King, J., Fishman, M. J., Shulman, M., Campbell, A. N. C., Greiner, M. G., Scodes, J. M., et al. (2022) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2022.100100 · Cited by 4
Telehealth Approaches to Improve Opioid Use Care in Pregnancy
Harper, L. M. (2021) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000607 · Cited by 4
Scoping review of intervention studies to improve opioid and alcohol use outcomes and links to care following inpatient detoxification
Livingston, N. A., Leviyah, X., Ameral, V., Hocking, E. C., & Timko, C. (2021) · Addiction Research & Theory · doi:10.1080/16066359.2021.1955356 · Cited by 4
Educating the community about the opioid epidemic and medications for opioid use disorder
Williams, J. M., Syed, M. A., Adesanya, A., Gardner, G., Chaguturu, V., & Coppola, K. M. (2022) · American Journal on Addictions · doi:10.1111/ajad.13287 · Cited by 4
Exploring Culturally Based Treatment Options for Opioid Use Disorders Among American Indian and Alaska Native Adults in California
Zeledon, I., Telles, V. M., Dickerson, D. L., Johnson, C. L., Schweigman, K., West, A. E., & Soto, C. (2022) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2022.83.613 · Cited by 5
Qualitative exploration of the psychological dimensions of telehealth shared medical appointments (SMAs) for buprenorphine prescribing
Greenberg, B., Oft, A. C., Lucitt, L., Haug, N. A., & Lembke, A. (2022) · Journal of Addictive Diseases · doi:10.1080/10550887.2022.2123669 · Cited by 4
The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research
Nunes, E. V., & McLellan, A. T. (2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001350 · Cited by 4
How Should the United States Respond to the Opioid Addiction and Overdose Epidemic?
Humphreys, K. N., & Pollack, H. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-11908-9_10 · Cited by 4
Correlates of death during outpatient treatment for opioid use disorder: A national study
Goldman, J. A., Samuels, E. A., Rich, J. D., & Marshall, B. D. L. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.01.003 · Cited by 4
Effects of live-online, group mindfulness training on opioid use and anxiety during buprenorphine treatment: A comparative effectiveness RCT
Rosansky, J. A., Howard, L., Goodman, H., Okst, K., Fatkin, T., Fredericksen, A. K., Sokol, R., Gardiner, P., Parry, G., Cook, B. L., et al. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107417 · Cited by 3
Self-citation
Real-world access to buprenorphine treatment in Philadelphia: A secret shopper study
Lowenstein, M., Davis, M. H., Aronowitz, S. V., Seeburger, E. F., & Grande, D. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112586 · Cited by 3
Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder
McHugh, R. K., Bailey, A. J., Weiss, R. D., & Fitzmaurice, G. M. (2024) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2024.100226 · Cited by 4
Self-citation
Alternative Reinforcers Enhance the Effects of Opioid Antagonists, but Not Agonists, on Oxycodone Choice Self-Administration in Nonhuman Primates
de Moura, F. B., & Kohut, S. J. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001911 · Cited by 3
Drive, instinct, reflex—Applications to treatment of anxiety, depressive and addictive disorders
Johnson, B., Brand, D., Zimmerman, E., & Kirsch, M. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.870415 · Cited by 3
Association of Opioid Use Disorder–Related Service Trajectories During Pregnancy and Postpartum Health Service Use: A Group-Based Multitrajectory Modeling Study
Fang, Y., Jeffery, A. D., Patrick, S. W., Young, J. L., Raffi, E. R., Harder, G. M., Osmundson, S. S., Phillippi, J. C., & Leech, A. A. (2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001434 · Cited by 2
Buprenorphine discontinuation and utilization of psychosocial services: a national study in the Veterans Health Administration
Cleary, E. N., Rollins, A. L., McGuire, A. B., Myers, L. J., & Quinn, P. D. (2025) · Addiction Science & Clinical Practice · doi:10.1186/s13722-025-00562-1 · Cited by 2
A clinical trial loses access to some of its experimental treatment conditions: What can be done?
Meyers-Ohki, S. E., Shulman, M., Weiss, R. D., Novo, P., Provost, S. E., Otterstatter, M. C., Bailey, G. L., Rotrosen, J., & Nunes, E. V. (2025) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2025.209854 · Cited by 2
Self-citation
The impact of nursing on health outcomes of people receiving medication for opioid use disorder: An integrative review
Alexander, K., Smith, J. M., Gerolamo, A. M., & Bernhardt, J. M. (2022) · Journal of Nursing Scholarship · doi:10.1111/jnu.12858 · Cited by 3
Opioid use disorder and role of yoga as an adjunct in management (OUDARYAM): Study protocol for a randomized controlled trial
Bhargav, H., Holla, B., Mahadevan, J., Jasti, N., Philip, M., Sharma, P., Vedamurthachar, A., Mehta, U. M., Varambally, S. S., Venkatasubramanian, G., et al. (2024) · Wellcome Open Research · doi:10.12688/wellcomeopenres.19392.1 · Cited by 2
Recovery from opioid use on a neuropsychoanalytic service
Meadon, R., Zhang‐James, Y., Aslam, S., & Johnson, B. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1409284 · Cited by 2
Prevalence and factors associated with opioid use disorder among adolescents with sickle cell disease in Mulago hospital, Uganda
Kwagala, C., Munube, D., Abbo, C., Muhwezi, W. W., & Mwesiga, E. K. (2024) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-024-00790-4 · Cited by 2
Opportunities to Innovate Health Policy and Practice to Improve Opioid Use Disorder Care for Older Adults Across the Care Continuum
Lowenstein, M., Perrone, J., Ritter, A. Z., & Aronowitz, S. V. (2025) · Innovation in Aging · doi:10.1093/geroni/igaf048 · Cited by 2
Behavioral counseling and abstinence‐contingent take‐home buprenorphine in general practitioners’ offices in Malaysia: a randomized, open‐label clinical trial
Schottenfeld, R. S., Chawarski, M. C., & Mazlan, M. (2021) · Addiction · doi:10.1111/add.15399 · Cited by 2
Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review
Shirk, S. D., Ameral, V., Kraus, S. W., Houchins, J. R., Kelly, M. M., Pugh, K. E., Reilly, E. D., & Desai, N. (2021) · Journal of Dual Diagnosis · doi:10.1080/15504263.2021.1942380 · Cited by 2
Psychosocial Treatment Methods
Peirce, J. M., Antoine, D. G., Hammond, A. S., & KIDORF, M. S. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197618431.013.25 · Cited by 2
Pharmacological and behavioral pain treatment strategies for patients with opioid use disorder
Ameral, V., Hickey, T. R., Reilly, E. D., Patterson, J. A., & Sofuoglu, M. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2506688 · Cited by 1
A Digital Therapeutic Mobile App, ReSET-O, as Adjunct to Medication Treatment for Opioid Use Disorder: A Randomized Clinical Trial at an Opioid Treatment Program
Kawasaki, S. S., Lehman, E. B., Kong, L., Spangler, A., Aydingolo, N., & Nunes, E. V. (2026) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001682 · Cited by 1
Effectiveness of opiate substitution treatment in reducing HIV risk behaviors among African, Caribbean, and Black people: a systematic review
Djiometio, J. N., Buzuayew, A., Mohamud, H., Njoroge, I., Kahan, M., & Nelson, L. E. (2021) · JBI Evidence Synthesis · doi:10.11124/jbies-20-00223 · Cited by 1
Health-Promoting Lifestyle Factors Among Opioid-Dependent Patients: A Scoping Review
Negi, P. S., Mathur, R., & Sarkar, S. (2023) · Journal of SAARC Psychiatric Federation · doi:10.4103/jspf.jspf_1_24 · Cited by 1
Adapting behavioral activation for patients receiving medications for opioid use disorder in primary care: a pilot study
Hooker, S. A., Kim, H., Lonergan, M. E., Busch, A. M., Nissly, T. J., & Levy, R. J. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1439946 · Cited by 1
Valid, Reproducible, Clinically Useful, Nonstigmatizing Terminology for the Disease and Its Treatment: Addiction, Substance Use Disorder, and Medication
Saitz, R. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000334 · Cited by 1
Chapter 24. Contingency Management
Stitzer, M. L., Sweeney, M. M., & Petry, N. M. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb24 · Cited by 1
Commentary on Socias et al. (2018): Clinical research perspectives on cannabis use in opioid agonist treatment
Timko, C., & Cucciare, M. A. (2018) · Addiction · doi:10.1111/add.14432 · Cited by 1
Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended‐release naltrexone in a controlled trial: implications for mechanism
Nunes, E. V., Bisaga, A. M., Krupitsky, E. M., Nangia, N., Silverman, B. L., Akerman, S. C., & Sullivan, M. A. (2020) · Addiction · doi:10.1111/add.15153 · Cited by 1
Questioning Precedent in Unprecedented Times: Psychosocial Interventions Supporting Medications for Opioid Use Disorder
Curtis, A. C., Werder, K., Reynolds, S., & Satterfield, J. M. (2021) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20210315-01 · Cited by 1
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacyPreprint
Lunerti, V., Shen, Q., Li, H., Benvenuti, F., Soverchia, L., Narendran, R., Weiss, F., Cannella, N., & Ciccocioppo, R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.21.550008 · Cited by 1
Commentary on Cochran et al.: Meeting people where they are in addictions research
Martin, C. E. (2024) · Addiction · doi:10.1111/add.16418 · Cited by 1
Commentary: Moving Toward Clear, Evidence-based, and Effective State Policies for Addiction Medicine
Parks, C. L. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000862
The Changing Landscape of Substance Use Disorders
(2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17201
Opioids
Edwards, K. A., Vowles, K. E., & Witkiewitz, K. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-28099-8_450-1
Opioids
Edwards, K. A., Vowles, K. E., & Witkiewitz, K. A. (2020) · Springer eBooks · doi:10.1007/978-3-319-24612-3_450
Medications for Opioid Use Disorder Do Help Patients.
Nguyen, K.-L., Forbriger, J., Forbriger, A., & Schwarz, E. S. (2022) · PubMed Central
Case 14: Opioid Use Disorder
Donald, R., & Marcovitz, D. E. (2022) · Springer eBooks · doi:10.1007/978-3-031-08376-1_24
Substance Use Disorders: Second Wave Approaches
Ecker, A. H., Hogan, J., Dawson, D. B., & Cucciare, M. A. (2022) · Springer eBooks · doi:10.1007/978-3-031-11677-3_24
Previous Treatments
Horák, M., & Verter, N. (2022) · Springer eBooks · doi:10.1007/978-3-031-16459-0_11
Cognitive behavioral therapy combined with head and face tuina/massage for negative emotions and sleep disorders in patients with protracted withdrawal symptoms: a study protocol for a randomized controlled trialPreprint
Yan, M., Shi, Y., Su, C., He, J., Li, J.-Y., Wu, N., Ye, S., Shi, Y., Zhou, C., Li, Z., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2790059/v1
The Impact of Individual Counseling on Treatment for Opioid Use
Mariolis, T., Wilson, A., & Chiodo, L. M. (2022) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000494
Does Prescription Length of Buprenorphine Influence Treatment Outcomes in Opioid Use Disorder? A Retrospective Cohort Study from North India
Ghosh, A., Mahintamani, T., Kathiravan, S., Swer, S. B., Basu, D., Mattoo, S. K., Subodh, B. N., & Singh, A. (2023) · Substance Use & Misuse · doi:10.1080/10826084.2023.2236196
Long-Term Treatment of Opioid Use Disorder with Medications
Wolfgang, A. S., Weimer, M. B., Na, P. J., Fiellin, D. A., & Muvvala, S. B. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197618431.013.23
Medications for Opioid Use Disorder (MOUDs): What Psychology Service Providers Should Know to Improve Correctional Care
Bassett, S. S., & Delaney, D. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-37480-7_11
Opioid induced hyperalgesia treated with low dose naltrexone improves painPreprint
Johnson, B., & Zhang‐James, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3275575/v1
Psychosocially-Assisted Pharmacological Treatment of Opioid Dependent Adults: A Systematic Review
Wayah, S. B., Waziri, P. M., Onyebuchi, C. M., Yahaya, G., & Chindo, B. A. (2022) · Ibom Medical Journal · doi:10.61386/imj.v15i3.264
Identifying the Heterogeneity in the Association between Workforce Diversity and Retention in Opioid Treatment among Black clientsPreprint
Kong, Y., Guerrero, E. G., Frimpong, J. A., Khachikian, T., Wang, S., D’Aunno, T. A., & Howard, D. L. (2024) · Research Square · doi:10.21203/rs.3.rs-3932153/v1
Chapter 41. Mood Disorders and Substance Use
(2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379620.lg41
Reference
Alderson, K. G., & Gladding, S. T. (2025) · Wiley eBooks · doi:10.1002/9781394347131.ref

Authors: Carroll, K. M., & Weiss, R. D.
Affiliations: Harvard University (US)
ORCID: Carroll, Kathleen M.
Weiss, Roger D.
Venue: American Journal of Psychiatry
Publisher: American Psychiatric Association Publishing
Published: 2017-08
Volume: 174
Issue: 8
Pages: 738-747
ISSN: 0002-953X (ISSN-L)
1535-7228
DOI: 10.1176/appi.ajp.2016.16070792
PMC: PMC5474206
OpenAlex: W2566316894
Cited by: 211
References: 67
Citations by year: 2026: 3 · 2025: 15 · 2024: 21 · 2023: 21 · 2022: 33 · 2021: 35 · 2020: 29 · 2019: 29 · 2018: 20 · 2017: 5
FWCI: 17.85
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: American Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (UL1TR001863)
National Institute on Drug Abuse (K24DA022288, P50DA009241, UG1DA015831)
National Center for Advancing Translational Sciences
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords: buprenorphine maintenance treatment, opioid use disorder, behavioral interventions, contingency management, office-based opioid treatment, medical management, stepped care, treatment retention, counseling, treatment discontinuation
MeSH terms: Behavior Therapy, Buprenorphine, Combined Modality Therapy, Heroin Dependence, Humans, Long-Term Care, Methadone, Opioid-Related Disorders, Outcome and Process Assessment, Health Care, Patient Compliance, Randomized Controlled Trials as Topic, Cocaine-Related Disorders, Patient Preference

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks